Skip to main content
NTHI
NASDAQ Life Sciences

President & 10% Owner Buys $153K in Shares Amidst Going Concern Warning

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$5.74
Mkt Cap
$136.648M
52W Low
$3.2
52W High
$15.5
52W Position info
79% above low
Off High info
63% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

NTHI sits 79% above its 52-week low of $3.2.

Summary

NEONC Technologies' President, Director, and 10% Owner, Amir F. Heshmatpour, purchased $153,398 worth of common stock, signaling confidence following recent disclosures of a going concern warning and a large shelf registration.


Key Events · Ownership and Investor Activity · NTHI

  • Key Insider Purchase

    Amir F. Heshmatpour, President, Director, and 10% Owner, acquired 25,000 shares of common stock in open market purchases.

  • Significant Investment

    The total value of the shares purchased was $153,398, representing approximately 0.112% of the company's market capitalization.

  • Confidence Amidst Challenges

    This purchase follows the company's recent disclosure of a going concern warning and a $300 million shelf registration, suggesting insider confidence in the company's outlook.


Analysis · NTHI · Life Sciences

This open market purchase by President Amir F. Heshmatpour is a notable vote of confidence, especially considering the company's recent disclosure of a going concern warning in its 10-K filing on March 31, 2026, and the subsequent S-3 shelf registration for up to $300 million on April 2, 2026. The insider's decision to acquire shares at prices between $6.09 and $6.32, totaling 0.112% of the company's market cap, suggests a belief in the company's future despite the financial challenges and potential dilution. Investors may view this as a positive counter-signal to the recent negative news.

How filings like this one have moved

In the 30 days to Sep 11, 2026, 30.2% of the 1961 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.20%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, NTHI was trading at $5.74 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $136.6M. The 52-week trading range was $3.20 to $15.50. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

NTHI - Latest Insights

NTHI
Sep 10, 2026, 10:27 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.72
Real-time Price: $3.60 info
Change: -$0.115 (-3%) info
Market Cap: $93.371M info
NTHI
Sep 10, 2026, 10:25 AM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $3.73
Real-time Price: $3.60 info
Change: -$0.125 (-3%) info
Market Cap: $93.371M info
NTHI
Sep 09, 2026, 12:43 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $3.60
Real-time Price: $3.60 info
Change: $0 (0%) info
Market Cap: $93.371M info
NTHI
Aug 12, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $5.18
Real-time Price: $3.60 info
Change: -$1.58 (-30%) info
Market Cap: $93.371M info
NTHI
Aug 12, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $4.88
Real-time Price: $3.60 info
Change: -$1.28 (-26%) info
Market Cap: $93.371M info